JP2024540168A5 - - Google Patents
Info
- Publication number
- JP2024540168A5 JP2024540168A5 JP2024525613A JP2024525613A JP2024540168A5 JP 2024540168 A5 JP2024540168 A5 JP 2024540168A5 JP 2024525613 A JP2024525613 A JP 2024525613A JP 2024525613 A JP2024525613 A JP 2024525613A JP 2024540168 A5 JP2024540168 A5 JP 2024540168A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274868P | 2021-11-02 | 2021-11-02 | |
| US63/274,868 | 2021-11-02 | ||
| PCT/US2022/079173 WO2023081722A2 (en) | 2021-11-02 | 2022-11-02 | Quality control method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540168A JP2024540168A (ja) | 2024-10-31 |
| JPWO2023081722A5 JPWO2023081722A5 (https=) | 2025-11-10 |
| JP2024540168A5 true JP2024540168A5 (https=) | 2025-11-10 |
Family
ID=84367177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525613A Pending JP2024540168A (ja) | 2021-11-02 | 2022-11-02 | 品質管理方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240093292A1 (https=) |
| EP (1) | EP4426858B1 (https=) |
| JP (1) | JP2024540168A (https=) |
| WO (1) | WO2023081722A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4705514A1 (en) * | 2023-05-01 | 2026-03-11 | Guardant Health, Inc. | Quality control method for enzymatic conversion procedures |
| WO2026072949A1 (en) * | 2024-09-27 | 2026-04-02 | Roche Sequencing Solutions, Inc. | Multi-modal risk stratification of minimum residual disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US20030017081A1 (en) | 1994-02-10 | 2003-01-23 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| AU2002359522A1 (en) | 2001-11-28 | 2003-06-10 | Applera Corporation | Compositions and methods of selective nucleic acid isolation |
| CA2519860C (en) | 2003-03-21 | 2018-01-16 | Santaris Pharma A/S | Short interfering rna (sirna) analogues |
| US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
| GB2533006B (en) | 2012-09-04 | 2017-06-07 | Guardant Health Inc | Systems and methods to detect copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| KR102423682B1 (ko) * | 2014-01-07 | 2022-07-20 | 푼다시오 프리바다 인스티튜트 데 메디시나 프레딕티바 이 페르소나리짜다 델 카세르 | 이중 가닥 dna 라이브러리 제공 방법 및 메틸화된 시토신의 확인을 위한 시퀀싱 방법 |
| GB201413318D0 (en) * | 2014-07-28 | 2014-09-10 | Cambridge Epigenetix Ltd | Nucleic acid sample preparation |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| CA3046007A1 (en) | 2016-12-22 | 2018-06-28 | Guardant Health, Inc. | Methods and systems for analyzing nucleic acid molecules |
| EP4567131A3 (en) | 2019-01-31 | 2025-09-03 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
| AU2020283042B2 (en) * | 2019-05-31 | 2026-02-19 | Freenome Holdings, Inc. | Methods and systems for high-depth sequencing of methylated nucleic acid |
| WO2021005537A1 (en) * | 2019-07-08 | 2021-01-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Bisulfite-free, whole genome methylation analysis |
| US11359238B2 (en) * | 2020-03-06 | 2022-06-14 | Singular Genomics Systems, Inc. | Linked paired strand sequencing |
-
2022
- 2022-11-02 JP JP2024525613A patent/JP2024540168A/ja active Pending
- 2022-11-02 EP EP22814588.4A patent/EP4426858B1/en active Active
- 2022-11-02 WO PCT/US2022/079173 patent/WO2023081722A2/en not_active Ceased
-
2023
- 2023-08-04 US US18/365,744 patent/US20240093292A1/en active Pending